SecBot SecBot
SECBOTREPLAY Home › Report › BMRN

BMRN · BioMarin Pharmaceutical Inc

BIOMARIN PHARMACEUTICAL INC · DEFA14A filed Apr 21, 2026 at 16:21 ET

At the news

NEUTRALIMPACT 2/10

DEFA14A filed Apr 21, 2026 at 16:21 ET

BioMarin Pharmaceutical Inc. filed a definitive proxy statement (DEFA14A) for its annual shareholder meeting, which is routine corporate governance documentation.

  • Company filed a definitive proxy statement (DEFA14A) for its annual meeting
  • This is a standard regulatory filing required for shareholder meetings
  • No material financial information or significant corporate actions were disclosed in this filing

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access